SG10202004908UA - Compound for use in the prevention and treatment of neurodegenerative diseases - Google Patents
Compound for use in the prevention and treatment of neurodegenerative diseasesInfo
- Publication number
- SG10202004908UA SG10202004908UA SG10202004908UA SG10202004908UA SG10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- compound
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15196984 | 2015-11-30 | ||
| EP16156775.5A EP3207925A1 (en) | 2016-02-22 | 2016-02-22 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202004908UA true SG10202004908UA (en) | 2020-06-29 |
Family
ID=57539219
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803422RA SG11201803422RA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
| SG10202004908UA SG10202004908UA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803422RA SG11201803422RA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11179358B2 (en) |
| EP (2) | EP3735965A1 (en) |
| JP (2) | JP7033073B2 (en) |
| CN (1) | CN108601758A (en) |
| AU (1) | AU2016364308B2 (en) |
| CA (1) | CA3003841A1 (en) |
| DK (1) | DK3383381T3 (en) |
| ES (1) | ES2804541T3 (en) |
| HU (1) | HUE050096T2 (en) |
| IL (1) | IL259383B (en) |
| MX (1) | MX2018006631A (en) |
| PT (1) | PT3383381T (en) |
| SG (2) | SG11201803422RA (en) |
| WO (1) | WO2017093363A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020295671A1 (en) | 2019-06-18 | 2022-01-20 | Universität Wien | Calixarene compounds and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489612A (en) | 1991-08-23 | 1996-02-06 | The University Of Alabama At Birmingham Research Foundation | Calixarene chloride-channel blockers |
| FR2782007B1 (en) | 1998-08-05 | 2001-02-23 | Centre Nat Rech Scient | USE OF CALIX (N) ARENES FOR THE TREATMENT OF FIBROTIC DISEASES |
| US8506959B2 (en) * | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| CN101052417A (en) * | 2004-08-09 | 2007-10-10 | 艾兰制药公司 | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| FR2888937B1 (en) * | 2005-07-21 | 2012-10-26 | Biomerieux Sa | METHOD OF DETECTING FCPA USING FCPA AGGREGATION AGENT AND FORM AGGREGATE CAPTURING AGENT |
| MY153198A (en) | 2006-03-29 | 2015-01-29 | Wista Lab Ltd | Inhibitors of protein aggregation |
| WO2013134371A1 (en) | 2012-03-06 | 2013-09-12 | Neuropore Therapies, Inc. | Methods and compounds to be used in the treatment of neurodegenerative diseases |
-
2016
- 2016-11-30 MX MX2018006631A patent/MX2018006631A/en unknown
- 2016-11-30 SG SG11201803422RA patent/SG11201803422RA/en unknown
- 2016-11-30 IL IL259383A patent/IL259383B/en unknown
- 2016-11-30 AU AU2016364308A patent/AU2016364308B2/en active Active
- 2016-11-30 EP EP20168424.8A patent/EP3735965A1/en not_active Withdrawn
- 2016-11-30 US US15/779,559 patent/US11179358B2/en active Active
- 2016-11-30 ES ES16809318T patent/ES2804541T3/en active Active
- 2016-11-30 PT PT168093185T patent/PT3383381T/en unknown
- 2016-11-30 SG SG10202004908UA patent/SG10202004908UA/en unknown
- 2016-11-30 EP EP16809318.5A patent/EP3383381B1/en active Active
- 2016-11-30 WO PCT/EP2016/079353 patent/WO2017093363A1/en active Application Filing
- 2016-11-30 CA CA3003841A patent/CA3003841A1/en active Pending
- 2016-11-30 CN CN201680069632.0A patent/CN108601758A/en active Pending
- 2016-11-30 DK DK16809318.5T patent/DK3383381T3/en active
- 2016-11-30 HU HUE16809318A patent/HUE050096T2/en unknown
- 2016-11-30 JP JP2018546767A patent/JP7033073B2/en active Active
-
2021
- 2021-12-10 JP JP2021200877A patent/JP2022027864A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017093363A1 (en) | 2017-06-08 |
| US11179358B2 (en) | 2021-11-23 |
| IL259383A (en) | 2018-07-31 |
| SG11201803422RA (en) | 2018-06-28 |
| CN108601758A (en) | 2018-09-28 |
| JP7033073B2 (en) | 2022-03-09 |
| AU2016364308B2 (en) | 2022-03-10 |
| EP3383381B1 (en) | 2020-04-08 |
| MX2018006631A (en) | 2019-01-30 |
| PT3383381T (en) | 2020-07-03 |
| EP3383381A1 (en) | 2018-10-10 |
| AU2016364308A1 (en) | 2018-05-17 |
| IL259383B (en) | 2022-07-01 |
| US20200360315A1 (en) | 2020-11-19 |
| DK3383381T3 (en) | 2020-07-13 |
| HUE050096T2 (en) | 2020-11-30 |
| JP2022027864A (en) | 2022-02-14 |
| JP2018535272A (en) | 2018-11-29 |
| EP3735965A1 (en) | 2020-11-11 |
| CA3003841A1 (en) | 2017-06-08 |
| ES2804541T3 (en) | 2021-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| LT3134125T (en) | Antibody-drug-conjugate and its use for the treatment of cancer | |
| PL3277280T3 (en) | Isomyosmine for use in the treatment of autoimmune diseases | |
| IL281585B (en) | Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| FI3197556T3 (en) | Composition for the prevention and/or treatment of allergy symptoms | |
| EP3107534A4 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
| EP3283457A4 (en) | Compounds and methods for the treatment of neurodegenerative diseases | |
| HUE045532T2 (en) | Preventive and/or therapeutic agent for immune diseases | |
| EP3208262A4 (en) | Compounds derived from 3-alkylamino-1h-indole acrylate, and the use thereof in the treatment of neurodegenerative diseases | |
| PT3413870T (en) | Igmesine for use in the treatment of neurodegenerative diseases | |
| IL252493A0 (en) | Compounds for use in the prevention or treatment of cancer | |
| IL249440B (en) | Compounds and pharmaceutical compositions comprising them for use in treating neurodegenerative diseases | |
| EP3377062C0 (en) | Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases | |
| IL259383A (en) | Compound for use in the prevention and treatment of neurodegenerative diseases | |
| PT3191112T (en) | Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation | |
| HK1252359A1 (en) | Combination of trazodone and gabapentin for the treatment of pain | |
| HK1246271A1 (en) | Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases | |
| IL257689B (en) | Pharmaceutical compositions and methods for the treatment of hypoxia-related diseases | |
| GB201518489D0 (en) | Methods for the treatment and prevention of ebola |